Papers published in Pubmed in last 60 days

(Data retrieved on Thu Mar 1 15:52:34 IST 2012 )

  1. Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: Pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS.
  2. The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with k-ras mutant Peptide.
  3. [The value of plasma pro-gastrin-releasing peptide, cytokeratin 19-fragments and carcinoembryonic antigen in patients with lung cancer].
  4. Evaluation of the use of amphipathic peptide-based protein carrier for in vitro cancer research.
  5. Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer. growth and reduces inflammation in rodent models. Hence, a degradation-resistant
  6. Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.
  7. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
  8. Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer.
  9. Human neutrophil peptides 1-3 as gastric cancer tissue markers measured by MALDI-imaging mass spectrometry: Implications for infiltrated neutrophils as a tumor target.
  10. Effects of the Synthetic Coprisin Analog Peptide, CopA3 in Pathogenic Microorganisms and Mammalian Cancer Cells.
  11. Gastrin-releasing peptide receptor expression in non-cancerous bronchial epithelia is associated with lung cancer: a case-control study.
  12. Molecular Imaging of Cancer with Radiolabeled Peptides and PET. for early monitoring of therapy outcomes, patient stratification, etc. This
  13. Peptide-Receptor Ligands In Imaging And Therapy Of Cancer. Padova, Italy.
  14. Chemically Modified Peptides Targeting the PDZ Domain of GIPC as a Therapeutic Approach for Cancer.
  15. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.
  16. Effects of low-dose human atrial natriuretic peptide for preventing post-operative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer.
  17. Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to
  18. Vasoactive Peptides with Angiogenesis-Regulating Activity Predict Cancer Risk in Males.
  19. In vitro and in vivo evaluation of a (64)Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer.
  20. A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro.
  21. Lytic peptides with improved stability and selectivity designed for cancer treatment.
  22. First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen.
  23. Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer.
  24. [Peptide vaccine treatment for colorectal cancer].